Hamilton, Australia · Founded 2011 · Privately Held (backing)
Developer of a needle-free vaccine delivery system designed to enhance the performance of existing and next-generation vaccines. Vaxxas is based in Hamilton, Australia and was founded in 2011. Its last reported valuation was $236 million in Aug 2025. It has raised $154 million.
Last reported valuation
$235.6M
Oct 2026
Priced at
—
Total raised
$154.3M
Last round
—
Cap table — not yet on record
Vaxxas's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vaxxas with a free account
·The complete investor list: 22 names
·Watch Vaxxas: the Monday email on marks, rounds and moves
